Industry News
BBI Financial Invests more than R$22m in Medelics (em português)
29 May 2015
(Valor Econômico) Winner of MIT innovation prize and cancer genome analysis company, Medelics, received a second round of investment of R$22m from fund BBI Financial.
Vencedora do prêmio MIT (Massachusetts Institute of Technology) de inovação no ano passado, a Mendelics é um exemplo típico de empresa que os investidores estão procurando. Foi o primeiro laboratório do país dedicado 100% a análise genômica de câncer e doenças raras.
You may be interested in...
-
Just Launched: LAVCA 2024 Top & Emerging Women Investors in Latin America
-
Advent International Acquires Colombia’s Siesa; Sapphire Ventures Leads USD120m Series C for Brazil’s Tractian
-
Allianz in LatAm; Across Capital’s ~USD115m Final Close; JICA, DFC, IDB Lab Newest Fund Commitments
-
Nominations Open for LAVCA Deal Awards; BTG Pactual TIG Secures USD500m for Reforestation Strategy